Keynote Presentation by Leroy Hood, President, Institute for Systems Biology (USA).
Reaching the goal of personalized medicine: what hills are left to climb?
Tuesday, March 8, 2011
- Trends in personalized medicine. Scott Jenkins, Vice President, Healthcare and Life Sciences, Dell Inc. (USA)
- Tiered computational strategies. Raymond Ng, Professor, Computer Science, University of British Columbia; Chief Informatics Officer, PROOF Centre of Excellence (CAN)
- Personalization – are we there yet? Bruce McManus, Professor, Department of Pathology and Laboratory Medicine, University of British Columbia; Director, PROOF Centre of Excellence (CAN)
- Large scale data integration for systems – level understanding of complex diseases. Sergio Baranzini, Associate Professor, Department of Neurology, University of California, San Francisco (USA)
- The need for critical appraisal of surrogates. Garret Fitzgerald, Chair, Department of Pharmacology; Director, Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine (USA)
- Can tools for personalized medicine meet the promise? How soon? Timothy Triche, Pathologist-in-Chief, Children’s Hospital (USA)
- The landscape of personalized medicine in Canada. Katherine Bonter, Director, Advocacy and Promotion, Cepmed (CAD)
- Can complex health systems adapt for higher quality in the face of fiscal constraint? Heather Manson, Director, Health Promotion, The Ontario Agency for Health Protection and Promotion (CAN)
- The business case for personalized medicines. Christopher-Paul Milne, Associate Director, Tufts Center for the Study of Drug Development (USA)
- Health systems adoption of personalized medicine: promise and obstacles. Scott Ramsey, Member, Cancer Prevention Faculty, Fred Hutchinson Cancer Research Centre (USA)
Wednesday, March 9, 2011
- Essential considerations in patient and cohort characterization. Rob Beanlands, Director, Molecular Functioning and Imaging, University of Ottawa Heart Institute (CAN)
- ‘Workable’ ethics for translational research. Bartha Knoppers, Director, Centre of Genomics and Policy, McGill University (CAN)
- Engagement of patient cohorts for better medicines, faster. Ramesh Ramanathan, Medical Director, Tgen Clinical Research Services (USA)
- Regulatory challenges and opportunities in the era of molecular solutions for health care. Janet Wilson-McManus, Chief Operating Officer, PROOF Centre of Excellence (CAN)
- Making it personal – challenges and strategies for patenting genetic technologies. Andrew Serafini, Partner, Intellectual Property Group, Fenwick and West (USA)
- How data sharing leads to knowledge. Scott Marshall, Assistant Professor, Medical Statistics and Bioinformatics, Leiden University Medical Center (NL)
- Technologies, methods and challenges to effective public data sharing and aggregation. Mark Wilkinson, Assistant Professor, Department of Medical Genetics, University of British Columbia; Principal Investigator, UBC James Hogg Research Centre, St. Paul’s Hospital (CAN)
- The future of personalized medicine today – leveraging new forms of patient information. Kareem Saad, National Sales Director, Healthcare and Life Sciences, Dell Inc. (USA)
- Crowdsourcing better medical decisions – can it be that simple? Chris Yoo, President and CEO, MedTrust Online (USA)
- Traditional versus future approaches to clinical medicine: how can we use personalized information for clinical medicine? Azita Sharif, Founder and CEO, Daedalus Software (USA)
- Building consortia for enhanced predictive, diagnostic and therapeutic care. David Wholley, Director, The Biomarkers Consortium at the Foundation for the NIH (USA)
- The ultimate deliverable: translation of personalized medicine to the clinic and patient. Daniel Bednarik, Director, Genomics and Bioinformatics, Cardiome Pharma (USA)
- ASK for confident decisions: harnessing the power of semantics. Erich Gombocz, Vice-President and Chief Scientific Officer, IO Informatics (USA)
Meeting on best practices in personalized medicine